$TRIL A bit pullback is all expected and deemed ok. Nothing goes straight up every day, particularly bio stocks. with a pipe there and M/A financial guru at the helm , longer term it is a huge win here, minimum is a out-licensing deal, bo highly possible when this cheap. Few years back LOXO licensed a pipe from Array and turned it into a 6 B buyout deal. TRIL owns these pipes and provides best value in the whole small bio world. Buy when everyone is selling!!!
  • 3
  • 2